Publicado

2024-03-04

Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression

Efecto agudo de la pregabalina sobre los comportamientos tipo depresivo y ansioso en ratas adultas en un modelo farmacológico de depresión

Efeito agudo da pregabalina nos comportamentos depressivos e ansiosos em ratos adultos em um modelo farmacológico de depressão

DOI:

https://doi.org/10.15446/rcciquifa.v52n3.111080

Palabras clave:

Reserpine, pregabalin, depression, anxiety, animal model (en)
Reserpina, pregabalina, depresión, ansiedad, modelo animal (es)
Reserpina, pregabalina, depressão, ansiedade , modelo animal (pt)

Autores/as

  • Alberto Casas Lucich Universidad Peruana Cayetano Heredia
  • Antony Brayan Campos Salazar Universidad Nacional Mayor de San Marcos
  • Victor Vasquez Matsuda Universidad Privada San Juan Bautista
  • Karla Masiel Yndigoyen Cueva Universidad Nacional Mayor de San Marcos
  • José Salvador Carrillo Universidad Privada San Juan Bautista
  • Giancarlo Ojeda Mercado Universidad Peruana Cayetano Heredia

Introduction: Due to lack of effective and fast-acting therapy, depression can become a life-threatening condition if not treated adequately. In fibromyalgia animal models, pregabalin has shown antidepressant properties. Compared to fluoxetine, the unusual fast-acting antidepressant properties of pregabalin offers the possibility to explore this GABA analogue in the context of depression. Objective: we evaluated the acute effect of pregabalin in a reserpine-induced animal models of depression. Method: rats were organized into four groups regarding their planned drug regimen: control (C), reserpine (R), reserpine + fluoxetine (RF) and reserpine + pregabalin (RP). The C group received only saline throughout the study. Depressive and anxiety-like behavior were tested using the force swimming test (FST) and the open field test (OFT), respectively. Results: Our data shows that both RP and RF groups have a significant longer mobility time (seconds) than the C group during the FST (RP: 44.76 ± 8.37 and RF: 65.86 ± 34.10 vs C: 21.80 ± 11.10, p<0.05 for both). No significant differences were observed in immobility time and climbing across all groups (p>0.05). On the other hand, RF and RP groups showed a reduced time spent in the center of the arena compared to control (p<0.05) in OFT, suggesting increased anxiety-like behavior. Conclusion: Our results show that pregabalin has an acute effect on depressive and can also acutely exert an unexpected anxiety-like behavior as well. Our work reveals an unexpected outcome in the search for fast-acting antidepressants.

 

Introducción: Debido a la falta de un tratamiento eficaz, el trastorno depresivo puede ser riesgoso para la vida si no es tratado adecuadamente. En modelos animales de fibromialgia, la pregabalina ha demostrado propiedades antidepresivas. En comparación con la fluoxetina, la inesperada acción antidepresiva aguda de la pregabalina ofrece la posibilidad de explorar este análogo del GABA en el contexto de la depresión. Objetivo: evaluar el efecto agudo de la pregabalina en un modelo animal de depresión inducida por reserpina. Método: las ratas fueron agrupadas en cuatro grupos según su régimen terapéutico: control (C), reserpina (R), reserpina + fluoxetina (RF) y reserpina + pregabalina (RP). El grupo C recibió sólo solución salina durante el estudio. Los comportamientos tipo depresivo y ansioso fueron evaluados mediante la prueba de nado forzada (PNF) y la prueba de campo abierto (PCA), respectivamente. Resultados: Nuestros datos mostraron que tanto el grupo RP como el RF tienen un tiempo de movilidad significativamente mayor que el grupo C durante la PNF (RP: 44,76s ± 8,37 y RF: 65,86s ± 34,10 vs C: 21,80s ± 11,10, p<0,05 para ambos). No se observaron diferencias significativas en el tiempo de inmovilidad y escalada entre los grupos (p>0,05). Por otro lado, en la PCA, los grupos RF y RP mostraron una reducción del tiempo en el centro de la arena en comparación con el control (p<0,05), lo que sugiere un mayor comportamiento tipo ansioso. Conclusión: Nuestros resultados sugieren que la pregabalina tiene un efecto agudo sobre los comportamientos tipo depresivo y ansioso.

 

Introdução: Devido à falta de terapia eficaz e de ação rápida, a depressão pode tornar-se uma condição potencialmente fatal se não for tratada adequadamente. Em modelos animais de fibromialgia, a pregabalina demonstrou propriedades antidepressivas. Em comparação com a fluoxetina, as propriedades antidepressivas incomuns de ação rápida da pregabalina oferecem a possibilidade de explorar este análogo do GABA no contexto da depressão. Objetivo: avaliamos o efeito agudo da pregabalina em modelos animais de depressão induzidos por reserpina. Método: os ratos foram organizados em quatro grupos quanto ao regime medicamentoso planejado: controle (C), reserpina (R), reserpina + fluoxetina (RF) e reserpina + pregabalina (RP). O grupo C recebeu apenas solução salina durante todo o estudo. Os comportamentos depressivos e ansiosos foram testados por meio do teste de natação forçada (FST) e do teste de campo aberto (OFT), respectivamente. Resultados: Nossos dados mostram que ambos os grupos RP e RF apresentam um tempo de mobilidade (segundos) significativamente maior do que o grupo C durante o FST (RP: 44,76 ± 8,37 e FR: 65,86 ± 34,10 vs C: 21,80 ± 11,10, p<0,05 para ambos). Não foram observadas diferenças significativas no tempo de imobilidade e escalada em todos os grupos (p>0,05). Por outro lado, os grupos RF e RP apresentaram redução do tempo gasto no centro da arena em comparação ao controle (p<0,05) no OFT, sugerindo aumento do comportamento semelhante à ansiedade. Conclusão: Nossos resultados mostram que a pregabalina tem um efeito agudo na depressão e também pode exercer de forma aguda um comportamento inesperado semelhante à ansiedade. Nosso trabalho revela um resultado inesperado na busca por antidepressivos de ação rápida.

 

Referencias

K. Smith, Mental health: A world of depression, Nature, 515, 180–181 (2014).

C. Otte, S.M. Gold, B.W. Penninx, C.M. Pariante, A. Etkin, M. Fava, D.C. Mohr, A.F. Schatzberg, Major depressive disorder, Nat. Rev. Dis. Prim., 2, 16065 (2016).

R.H. Belmaker, G. Agam, Major depressive disorder, N. Engl. J. Med., 358, 55–68 (2008).

B.D. Hare, R.S. Duman, Prefrontal cortex circuits in depression and anxiety: Contribution of discrete neuronal populations and target regions, Mol. Psychiatry, 25, 2742–2758 (2020).

J. Flint, K.S. Kendler, The genetics of major depression, Neuron, 81, 484–503 (2014).

B. Labonté, O. Engmann, I. Purushothaman, C. Menard, J. Wang, C. Tan, J.R. Scarpa, et al., Sex-specific transcriptional signatures in human depression, Nat. Med., 23, 1102–1111 (2017).

R.C. Kessler, W.T. Chiu, O. Demler, K.R. Merikangas, E.E. Walters, Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication, Arch. Gen. Psychiatry, 62, 617–627 (2005).

S.G. Kornstein, A.F. Schatzberg, M.E. Thase, K.A. Yonkers, J.P. McCullough, G.I. Keitner, et al., Gender differences in chronic major and double depression, J. Affect. Disord., 60, 1–11 (2000).

R.C. Kessler, K.A. McGonagle, M. Swartz, D.G. Blazer, C.B. Nelson, Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence, J. Affect. Disord., 29, 85–96 (1993).

M. Touchant, B. Labonté, Sex-specific brain transcriptional signatures in human MDD and their correlates in mouse models of depression, Front. Behav. Neurosci., 16, 845491 (2022).

M. Maitra, H. Mitsuhashi, R. Rahimian, A. Chawla, J. Yang, L.M. Fiori, et al., Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes, Nat. Commun., 14, 2912 (2023).

E. Beurel, M. Toups, C.B. Nemeroff, The bidirectional relationship of depression and inflammation: Double trouble, Neuron, 107, 234–256 (2020).

S. Marwaha, E. Palmer, T. Suppes, E. Cons, A.H. Young, R. Upthegrove, Novel and emerging treatments for major depression, Lancet, 401, 141–153 (2023).

E.M. González-Soler, A. Blasco-Serra, G.M. Alfosea-Cuadrado, M. Igual-López, J. Orduña-Valls, C. Tornero-Tornero, et al., Chronic pregabalin treatment ameliorates pain, but not depressive-like behaviors, in a reserpine-induced myalgia model in rats, Pain Physician, 23, E581–E590 (2020).

Y. Wang, H. Yang, C. Shen, J. Luo, Morphine and pregabalin in the treatment of neuropathic pain, Exp. Ther. Med., 13, 1393–1397 (2017).

I.J. Onakpoya, E.T. Thomas, J.J. Lee, B. Goldacre, C.J. Heneghan, Benefits and harms of pregabalin in the management of neuropathic pain: A rapid review and meta-analysis of randomised clinical trials, BMJ Open, 9, e023600 (2019).

W. Häuser, F. Petzke, N. Üçeyler, C. Sommer, Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: A systematic review with meta-analysis, Rheumatology (Oxford), 50, 532–543 (2011).

S. Quilici, J. Chancellor, M. Löthgren, D. Simon, G. Said, T.K. Le, A. Garcia- Cebrian, B. Monz, Meta-analysis of duloxetine vs pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain, BMC Neurol., 9, 6 (2009).

W. Häuser, F. Petzke, C. Sommer, Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome, J. Pain, 11, 505–521 (2010).

M.B. Generoso, A.P. Trevizol, S. Kasper, H.J. Cho, Q. Cordeiro, P. Shiozawa, Pregabalin for generalized anxiety disorder: An updated systematic review and meta-analysis, Int. Clin. Psychopharmacol., 32, 49–55 (2017).

S. Jayakumar, G. Raghunath, S. Ilango, J. Vijayakumar, R. Vijayaraghavan, Effect of fluoxetine on the hippocampus of wistar albino rats in cold restraint stress model, J. Clin. Diagnostic Res., 11, AF01–AF06 (2017).

S.C. Dulawa, K.A. Holick, B. Gundersen, R. Hen, Effects of chronic fluoxetine in animal models of anxiety and depression, Neuropsychopharmacology, 29, 1321–1330 (2004).

D. Kuzay, E. Dileköz, Ç. Özer, Effects of thymoquinone in a rat model of reserpine- induced depression, Braz. J. Pharm. Sci., 58, e19847 (2022).

K.R. Lezak, G. Missig, W.A. Carlezon, Behavioral methods to study anxiety in rodents, Dialogues Clin. Neurosci., 19, 181-191 (2017).

F.C. Gabriel, D.O. de Melo, R. Fráguas, N.C. Leite-Santos, R.A. Mantovani da Silva, E. Ribeiro, Pharmacological treatment of depression: A systematic review comparing clinical practice guideline recommendations, PLoS One, 15, e0231700 (2020).

T. Hedgecock, A. Phillips, B. Ludrick, T. Golden, N. Wu, Molecular mechanisms and applications of a reserpine-induced rodent model, SSR Inst. Int. J. Life Sci., 5, 2160–2167 (2019).

J. Moncrieff, R.E. Cooper, T. Stockmann, S. Amendola, M.P. Hengartner, M.A. Horowitz, The serotonin theory of depression: A systematic umbrella review of the evidence, Mol. Psychiatry, 28, 3243–3256 (2023).

Q. Huang, H. Jiang, X. Hao, T.R. Minor, Brain IL-1 beta was involved in reserpine- induced behavioral depression in rats, Acta Pharmacol. Sin., 25, 293–296 (2004).

P. Ruiz, A. Calliari, R.M. Pautassi, Reserpine-induced depression is associated in female, but not in male, adolescent rats with heightened, fluoxetine-sensitive, ethanol consumption, Behav. Brain Res., 348, 160–170 (2018).

R.F. Ahmed, R.F. Abdel-Rahman, O.A.H.A. Farid, S.A. El-Marasy, A.F. Hessin, Combined hepatoprotective and antidepressant effects of resveratrol in an acute model of depression, Bull. Fac. Pharm., Cairo Univ., 52, 191–197 (2014).

Y. Li, Q. Yin, B. Wang, T. Shen, W. Luo, T. Liu, Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment, Front. Pharmacol., 13, 944376 (2022)

D. Drapier, D. Bentué-Ferrer, B. Laviolle, B. Millet, H. Allain, M. Bourin, J.M. Reymann, Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze, Behav. Brain Res., 176, 202–209 (2007).

M. Cheung, M. Parmar, Reserpine, StatPearls [Internet]. URL: https://www.ncbi.nlm.nih.gov/books/NBK557767/, accessed September 1, 2023.

Cómo citar

APA

Casas Lucich, A., Campos Salazar, A. B., Vasquez Matsuda, V., Yndigoyen Cueva, K. M., Salvador Carrillo, J. y Ojeda Mercado, G. (2024). Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression. Revista Colombiana de Ciencias Químico-Farmacéuticas, 52(3). https://doi.org/10.15446/rcciquifa.v52n3.111080

ACM

[1]
Casas Lucich, A., Campos Salazar, A.B., Vasquez Matsuda, V., Yndigoyen Cueva, K.M., Salvador Carrillo, J. y Ojeda Mercado, G. 2024. Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression. Revista Colombiana de Ciencias Químico-Farmacéuticas. 52, 3 (mar. 2024). DOI:https://doi.org/10.15446/rcciquifa.v52n3.111080.

ACS

(1)
Casas Lucich, A.; Campos Salazar, A. B.; Vasquez Matsuda, V.; Yndigoyen Cueva, K. M.; Salvador Carrillo, J.; Ojeda Mercado, G. Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression. Rev. Colomb. Cienc. Quím. Farm. 2024, 52.

ABNT

CASAS LUCICH, A.; CAMPOS SALAZAR, A. B.; VASQUEZ MATSUDA, V.; YNDIGOYEN CUEVA, K. M.; SALVADOR CARRILLO, J.; OJEDA MERCADO, G. Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression. Revista Colombiana de Ciencias Químico-Farmacéuticas, [S. l.], v. 52, n. 3, 2024. DOI: 10.15446/rcciquifa.v52n3.111080. Disponível em: https://revistas.unal.edu.co/index.php/rccquifa/article/view/111080. Acesso em: 3 ago. 2024.

Chicago

Casas Lucich, Alberto, Antony Brayan Campos Salazar, Victor Vasquez Matsuda, Karla Masiel Yndigoyen Cueva, José Salvador Carrillo, y Giancarlo Ojeda Mercado. 2024. «Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression». Revista Colombiana De Ciencias Químico-Farmacéuticas 52 (3). https://doi.org/10.15446/rcciquifa.v52n3.111080.

Harvard

Casas Lucich, A., Campos Salazar, A. B., Vasquez Matsuda, V., Yndigoyen Cueva, K. M., Salvador Carrillo, J. y Ojeda Mercado, G. (2024) «Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression», Revista Colombiana de Ciencias Químico-Farmacéuticas, 52(3). doi: 10.15446/rcciquifa.v52n3.111080.

IEEE

[1]
A. Casas Lucich, A. B. Campos Salazar, V. Vasquez Matsuda, K. M. Yndigoyen Cueva, J. Salvador Carrillo, y G. Ojeda Mercado, «Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression», Rev. Colomb. Cienc. Quím. Farm., vol. 52, n.º 3, mar. 2024.

MLA

Casas Lucich, A., A. B. Campos Salazar, V. Vasquez Matsuda, K. M. Yndigoyen Cueva, J. Salvador Carrillo, y G. Ojeda Mercado. «Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression». Revista Colombiana de Ciencias Químico-Farmacéuticas, vol. 52, n.º 3, marzo de 2024, doi:10.15446/rcciquifa.v52n3.111080.

Turabian

Casas Lucich, Alberto, Antony Brayan Campos Salazar, Victor Vasquez Matsuda, Karla Masiel Yndigoyen Cueva, José Salvador Carrillo, y Giancarlo Ojeda Mercado. «Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression». Revista Colombiana de Ciencias Químico-Farmacéuticas 52, no. 3 (marzo 4, 2024). Accedido agosto 3, 2024. https://revistas.unal.edu.co/index.php/rccquifa/article/view/111080.

Vancouver

1.
Casas Lucich A, Campos Salazar AB, Vasquez Matsuda V, Yndigoyen Cueva KM, Salvador Carrillo J, Ojeda Mercado G. Acute effect of pregabalin on depressiveand anxiety-like behaviors in adult rats in a pharmacologic model of depression. Rev. Colomb. Cienc. Quím. Farm. [Internet]. 4 de marzo de 2024 [citado 3 de agosto de 2024];52(3). Disponible en: https://revistas.unal.edu.co/index.php/rccquifa/article/view/111080

Descargar cita

CrossRef Cited-by

CrossRef citations0

Dimensions

PlumX

Visitas a la página del resumen del artículo

108

Descargas

Los datos de descargas todavía no están disponibles.